ACR Alpine Capital Research’s MetLife MET Stock Holding History

ACR Alpine Capital Research’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-154	Closed	-$7K	–	22
2014 Q4	$7K	Sell	154 -7,139	-98%	-$339K	﹤0.01%	20
2014 Q3	$349K	Hold	7,293	–	–	0.05%	19
2014 Q2	$361K	Hold	7,293	–	–	0.06%	17
2014 Q1	$343K	Buy	+7,293	New	+$335K	0.06%	19

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACR Alpine Capital Research's MET Position: Q1 2015 in Review

ACR Alpine Capital Research sold out of MetLife (MET) in Q1 2015, closing a stake of 154 shares — an estimated $7K sold.

ACR Alpine Capital Research first reported a position in MET in Q1 2014 and held it in 4 quarters. The position peaked at $361K in Q2 2014. 944 funds tracked by Wall St. Rank hold MET as of Q1 2015.

ACR Alpine Capital Research reported no remaining MetLife position as of Q1 2015 after selling out during the quarter.
ACR Alpine Capital Research sold 154 MetLife shares in Q1 2015, an estimated $7K.
ACR Alpine Capital Research first reported a position in MetLife in Q1 2014 and held it in 4 quarters.
ACR Alpine Capital Research's MetLife position peaked at $361K in Q2 2014.
944 funds tracked by Wall St. Rank held MetLife as of Q1 2015.

Based on ACR Alpine Capital Research's 13F filing for Q1 2015, filed 13 May 2015.